A significantly increased number and percentage of B cells in depressed subjects: results of flow cytometric measurements.

[1]  P. Cosyns,et al.  Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: Further evidence for an inflamatory process during that illness , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  P. Cosyns,et al.  Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. , 1992, Journal of psychiatric research.

[3]  E. Bosmans,et al.  Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining , 1992, Psychological Medicine.

[4]  G. Vanhoof,et al.  Decreased serum dipeptidyl peptidase IV activity in major depression , 1991, Biological Psychiatry.

[5]  E. Bosmans,et al.  Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. , 1991, Journal of affective disorders.

[6]  M. Maes,et al.  Clinical subtypes of unipolar depression: Part I. A validation of the vital and nonvital clusters , 1990, Psychiatry Research.

[7]  M. Maes,et al.  Clinical subtypes of unipolar depression: Part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups , 1990, Psychiatry Research.

[8]  T. Patterson,et al.  Reduction of immune function in life stress and depression , 1990, Biological Psychiatry.

[9]  E. Bosmans,et al.  Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. , 1990, Neuropsychobiology.

[10]  N. Rose.  Pathogenic mechanisms in autoimmune diseases. , 1989, Clinical immunology and immunopathology.

[11]  Z. Kronfol,et al.  Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls , 1989, Acta psychiatrica Scandinavica.

[12]  Douglas Mossman,et al.  Assessing improvements in the Dexamethasone Suppression Test using receiver operating characteristic analysis , 1989, Biological Psychiatry.

[13]  R. Bond,et al.  Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. , 1989, Archives of general psychiatry.

[14]  C. Pedersen,et al.  Major depression and immunity: Preliminary evidence of decreased natural killer cell populations , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  W. J. Martin,et al.  Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. , 1988, Arthritis and rheumatism.

[16]  D. Janowsky,et al.  Cellular immunity and the hypothalamic-pituitary axis in major affective disorder: A preliminary study , 1988, Psychiatry Research.

[17]  R. Wolf,et al.  Soluble interleukin-2 receptors in systemic lupus erythematosus. , 1988, Arthritis and rheumatism.

[18]  Warrington Rj.  Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. A role for overproduction of interleukin-2 in human autoimmunity? , 1988 .

[19]  É. Zarifian,et al.  Anti-histone antibodies in schizophrenia and affective disorders , 1988, Psychiatry Research.

[20]  T. Nagatsu,et al.  Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis. , 1987, Clinical chemistry.

[21]  M. Maes,et al.  The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories. , 1986, Journal of affective disorders.

[22]  H. Lassmann,et al.  Recombinant interleukin 2 (IL-2) promotes T cell line-mediated neuroautoimmune disease , 1986, Journal of Neuroimmunology.

[23]  E. Clark,et al.  The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle. , 1985, Journal of immunology.

[24]  D. Nelson,et al.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. , 1985, Journal of immunology.

[25]  A. Feller,et al.  Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IV. , 1985, Cellular immunology.

[26]  H. Demuth,et al.  Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. , 1984, The Biochemical journal.

[27]  K. Davis,et al.  Lymphocyte function in major depressive disorder. , 1984, Archives of general psychiatry.

[28]  T. Tanaka,et al.  Decreased serum levels of various hydrolytic enzymes in patients with rheumatoid arthritis. , 1984, Biochemistry international.

[29]  D. Dennig,et al.  Dipeptidylaminopeptidase IV (DAP IV) activity in normal and malignant T-cell subsets as defined by monoclonal antibodies. , 2009, Scandinavian journal of haematology.

[30]  B. Carroll,et al.  Impaired lymphocyte function in depressive illness. , 1983, Life sciences.

[31]  G. Marti,et al.  B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. , 1983, Journal of immunology.

[32]  B. Waters,et al.  Lymphocyte subpopulations and mitogenic responses of lymphocytes in manic-depressive disorders. , 1982, Biological psychiatry.

[33]  K. Itoh,et al.  Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B, and K cell traffic in the peripheral blood. , 1981, Journal of immunology.

[34]  T. Nagatsu,et al.  Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis and systemic lupus erythematosus. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[35]  A. Coppen,et al.  Antinuclear antibodies, affective disorders and lithium therapy. , 1977, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[36]  W. Amery,et al.  Antinuclear factor-positive mental depression: a single disease entity? , 1976, Biological psychiatry.

[37]  E. Johnstone,et al.  Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. , 1975, British medical journal.

[38]  S. Gershon,et al.  Antinuclear factor in psychiatric patients. , 1973, Biological psychiatry.

[39]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.